Latest from Almac
January 10th, 2019
Ireland’s science centre, W5, opens “MED-Lab”
Integrated Multi-Site Commercial Product Transfer
October 16th, 2018
Almac Launches Brexit Resource Hub
Evaluation of the claraT Total mRNA Report
Partnering to advance human healthExplore our locations
Brexit - A Seamless Solution
Almac recognises that you need bespoke solutions to suit your needs. Only we can combine the expertise from our world leading range of specialised drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation.
Almac Diagnostics is our stratified medicine business unit, specialising in biomarker driven clinical trials. Our global laboratories, in the UK and US, offer tailored solutions from discovery to commercialisation: biomarker discovery, assay development & validation, CDx development & commercialisation. Your clinical trial diagnostic partner.
Almac Discovery is a research driven, oncology business unit within Almac dedicated to the discovery and development of novel, innovative approaches to the treatment of cancer. We focus on early stage development and partner programmes with the pharmaceutical industry at the discovery to preclinical stage.
Asia Pharma R&D Leaders Conference
21 January 2019 Beijing, China
Lunch and learn: Playing it cool – cold chain solutions for your clinical supply chain
30 January 2019 San Diego
Workshop: Clinical Trial Supply and Technology: A proven approach to achieve supply chain harmony
31 January 2019
06 February 2019 New York City, USA